Research Priorities - Substance Use Disorder
  • Article
  • May 21 2024

The industries that suffered the most overdose deaths were surprising, according to research conducted by the Kentucky Injury Prevention and Research Center (KIPRC) at UK's College of Public Health

  • Article
  • Apr 16 2024

UK doctoral student Kara Cook was recently awarded a Substance Use Priority Research Area (SUPRA) Graduate Student Grant to explore the unintended consequences of classifying controlled substances.

  • Article
  • Mar 7 2024

That’s according to a new RAND study, co-authored by Julie Cerel, Ph.D., professor in the College of Social Work at the University of Kentucky, and published in the American Journal of Public Health.

  • Article
  • Feb 2 2024

An unusual spike in drug overdoses in Lexington, recently has spurred the Lexington-Fayette County Health Department to advise people, especially those with substance use disorder or those connected to someone with it, to carry naloxone.

  • Article
  • Jan 26 2024

A community advisory board is marking more than a year of impacting research at the University of Kentucky.

  • Article
  • Jan 10 2024

The Substance Use Research Priority Area has set the date for its sixth annual Substance Use Research Event (SURE) and registration is currently open.

  • Article
  • Dec 4 2023

A team of researchers at the University of Kentucky is working to better understand the impact of opioid use disorder on mothers and babies.

  • Article
  • Nov 29 2023

The grant, in collaboration with the Kentucky Department for Public Health, provides opportunities to strengthen ongoing efforts to combat Kentucky’s drug overdose crisis and reduce overdose-related harms.

  • Article
  • Oct 31 2023

The $2.65 million five-year grant from the National Institute on Drug Abuse (NIDA) will support research to understand how xylazine and fentanyl change the brain’s signaling pathways.

  • Article
  • Oct 24 2023

Published in JAMA Network Open, new findings are adding to a growing body of evidence demonstrating positive outcomes associated with telemedicine for treating opioid use disorder.